中国式生物多样性产业化:理论逻辑、运行机制与实现路径
创新与发展学报 · 01.11.2026 · 1 (1) · 1-8
DOI: 10.65192/7jqyfz97 ↗Kurz gefasst
Fachartikel in der Zeitschrift 创新与发展学报, online erschienen am 01.11.2026. Verfasst von 礼生 王 und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The tension between biodiversity loss and development rights makes the compatibility of conservation and use a core problem of global biodiversity governance. This paper explains the theoretical logic of Chinese-style biodiversity industrialization and builds a tractable model. Drawing on natural capital theory, institutional economics and the social–ecological systems framework, it proposes a closed-loop framework of ecological red line, value revelation, rights reconfiguration, industrial organization and benefit reinvestment, develops a dynamic conservation–use–distribution model, and illustrates the mechanisms with the practices of Lishui, Nanping and national parks. The results show that (1) reinvestment intensity η scales the sustainable use ceiling by 1/(1−η); (2) when the ecological threshold exceeds half of the baseline level, the market-optimal use intensity necessarily breaches the threshold, while the profit cost of observing the red line is only (2κ−1)²; and (3) an institutional-supply threshold exists above which conservation, community and investor participation constraints hold simultaneously. Four implementation pathways are derived by ecological sensitivity and institutional capacity, offering a theoretical account and policy instruments for China's practice under the Kunming–Montreal Global Biodiversity Framework.
Zitieren
APA
王, 礼., & 魏, 行. (2026). 中国式生物多样性产业化:理论逻辑、运行机制与实现路径. 创新与发展学报, 1(1), 1-8. https://doi.org/10.65192/7jqyfz97
Vancouver
王 礼, 魏 行. 中国式生物多样性产业化:理论逻辑、运行机制与实现路径. 创新与发展学报. 2026;1(1):1-8. doi:10.65192/7jqyfz97
BibTeX
@article{2026,
author = {王, 礼生 and 魏, 行智},
title = {中国式生物多样性产业化:理论逻辑、运行机制与实现路径},
journal = {创新与发展学报},
year = {2026},
volume = {1},
number = {1},
pages = {1--8},
doi = {10.65192/7jqyfz97}
}
EUVIMED